High doses of psilocybin—the active ingredient in magic mushrooms—appears to have a similar effect on depressive symptoms as the selective serotonin reuptake inhibitor (SSRI) drug escitalopram, suggests a systematic review and meta-analysis published in The BMJ today.
Medical Xpress – latest medical and health news stories
